Researchers at Monash Health have published findings related to vocal cord dysfunction/inducible laryngeal obstruction(s) (VCD/ILO) in relation to incident-associated VCD which may be related to vaccination.

Their findings are related to a case series of ten individuals who were initially labelled as having experienced anaphylaxis following COVID-19 vaccination. These individuals were referred on to a specialist allergy service, where 9 out of the 10 received a second dose of the same COVID-19 vaccine that caused their initial reaction.  It was found that 2 out of the 10 individuals met the Brighton Criteria for anaphylaxis, and symptoms recurred in 8 of the 9 individuals who received a second dose, mirroring their initial reactions which had been diagnosed as anaphylaxis.

Clinical features of VCD/ILO overlap with those of the Brighton Criteria for vaccine-related anaphylaxis, with this research demonstrating the need for providers to be able to differentiate between anaphylaxis and VCD/ILO.

To read the article in full, please follow the link below:

过敏和临床免疫学杂志:声带功能障碍/诱导性喉阻塞模仿 SARS-CoV-2 (COVID-19) 疫苗接种期间的过敏反应

For further information on how to differentiate between anaphylaxis and an acute stress response, refer to the animation on the MVEC:过敏和免疫 reference page.

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个